SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SWOG | S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | Y | 1 Tissue for MammaPrint testing | 960 | 485 | 432 | 256 | 156 | 55 | 13 | 11/27/2023 | 358 | 128 |
485 | 432 | 256 | 156 | 55 | 13 | |||||||||
2 | Y | 2 SOC Chemotherapy | 80 | 76 | 43 | 28 | 9 | 1 | 11/27/2023 | |||||
3 SOC Chemotherapy + Durvalumab | 80 | 76 | 44 | 27 | 12 | 3 | ||||||||
160 | 152 | 87 | 55 | 21 | 4 | |||||||||
S2212-Breast, TNBC, Neoadj Chemo + Pembro | 1 | Y | 1 Carbo + Paclitaxel + Pembro -> AC + Pembro | 2400 | 299 | 238 | 128 | 69 | 22 | 5 | 09/15/2023 | 374 | 151 | |
2 Carbo + Docetaxel + Pembro | 305 | 250 | 134 | 74 | 22 | 5 | ||||||||
604 | 488 | 262 | 143 | 44 | 10 | |||||||||
Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 55 | 13 | 8 | 4 | 1 | 0 | 03/11/2021 | 425 | 206 | |
55 | 13 | 8 | 4 | 1 | 0 | |||||||||
A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab | 1 | E | Total Registrations | 23 | 18 | 11 | 8 | 3 | 1 | 08/24/2023 | 357 | 183 | ||
23 | 18 | 11 | 8 | 3 | 1 | |||||||||
MA39-BREAST, Node-Pos, Reg RT vs No Reg RT | 1 | E | Total Registrations | 53 | 24 | 12 | 10 | 1 | 0 | 10/18/2019 | 378 | 150 | ||
53 | 24 | 12 | 10 | 1 | 0 | |||||||||
2 | E | Total Registrations | 51 | 23 | 11 | 9 | 2 | 0 | 10/18/2019 | |||||
51 | 23 | 11 | 9 | 2 | 0 | |||||||||
NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | 135 | 55 | ||
1 | 0 | 0 | 0 | 0 | 0 | |||||||||
NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | ||||
7 | 0 | 0 | 0 | 0 | 0 | |||||||||
No | A012301-Breast, Early Stg, Tamoxifen | 1 | E | Total Registrations | 2 | 2 | 2 | 2 | 1 | 0 | 03/07/2025 | 247 | 60 | |
2 | 2 | 2 | 2 | 1 | 0 | |||||||||
EA1211-Breast, HER2+, NeoAdj Therapy | 1 | E | Total Registrations | 8 | 8 | 6 | 1 | 0 | 0 | 05/06/2024 | 129 | 59 | ||
8 | 8 | 6 | 1 | 0 | 0 | |||||||||
NRGBR007-Breast, Stg I, De-Escalation of Breast RT | 1 | E | Total Registrations | 24 | 16 | 12 | 6 | 2 | 0 | 06/01/2022 | 392 | 176 | ||
24 | 16 | 12 | 6 | 2 | 0 | |||||||||
2 | E | Total Registrations | 22 | 14 | 10 | 6 | 2 | 0 | 06/01/2022 | |||||
22 | 14 | 10 | 6 | 2 | 0 | |||||||||
NRGBR008-Breast, LowRisk HER2+, Radiotherapy | 1 | E | Total Registrations | 1 | 1 | 1 | 1 | 0 | 0 | 03/10/2025 | 1 | 1 | ||
1 | 1 | 1 | 1 | 0 | 0 | |||||||||
NRGBR009-Breast, EarlyStg, Adjuvant Chemo | 1 | E | Total Registrations | 12 | 9 | 6 | 3 | 1 | 1 | 01/31/2024 | 435 | 187 | ||
12 | 9 | 6 | 3 | 1 | 1 | |||||||||
2 | E | Total Registrations | 12 | 9 | 6 | 3 | 1 | 1 | 01/31/2024 | |||||
12 | 9 | 6 | 3 | 1 | 1 | |||||||||